O

    Outset Medical Inc (OM)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $3.82
    -0.12 (-3.05%)

    Market Cap: $71.81M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    44%(11/25)
    Avg Surprise
    -7.97%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.69
    Range$-0.77 - $-0.64
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate Drift
    90d ago$-0.62+11.0%
    60d ago$-0.62+11.0%
    30d ago$-0.62+11.0%
    7d ago$-0.65+6.7%
    Current$-0.69
    Revenue Consensus
    $31M
    Range$31M - $32M
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.89
    Range$-0.95 - $-0.83
    3 analysts
    Revenue Consensus
    $37M
    Range$36M - $38M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.89---
    Sep 26EST
    		-$-0.69---
    Jun 26
    Reported Aug 6
    		$-0.94$-0.88-6.82%Miss-11.9%
    Mar 26
    Reported May 7
    		$-0.83$-0.79-5.06%Miss+74.4%
    Dec 25
    Reported Feb 11
    		$-0.84$-0.67-25.37%Miss+84.9%
    Sep 25
    Reported Nov 10
    		$-0.69$-0.65-6.15%Miss+88.2%
    Jun 25
    Reported Aug 6
    		$-0.84$-0.98+14.29%Beat+88.1%
    Mar 25
    Reported May 7
    		$-3.24$-0.94-244.68%Miss+62.1%
    Dec 24
    Reported Feb 19
    		$-5.55$-6.19+10.34%Beat+37.3%
    Sep 24
    Reported Nov 6
    		$-5.85$-6.32+7.44%Beat+45.1%
    Jun 24
    Reported Aug 7
    		$-7.05$-6.79-3.83%Miss+31.9%
    Mar 24
    Reported May 8
    		$-8.55$-8.23-3.89%Miss+20.8%
    Dec 23
    Reported Feb 21
    		$-8.85$-9.22+4.01%Beat+16.9%
    Sep 23
    Reported Nov 7
    		$-10.65$-10.00-6.50%Miss-1.4%
    Jun 23
    Reported Aug 2
    		$-10.35$-10.89+4.96%Beat+10.4%
    Mar 23
    Reported May 3
    		$-10.80$-10.35-4.35%Miss-7.5%
    Dec 22
    Reported Feb 13
    		$-10.65$-11.19+4.83%Beat+7.8%
    Sep 22
    Reported Nov 8
    		$-10.50$-10.57+0.66%Beat-18.6%
    Jun 22
    Reported Aug 1
    		$-11.55$-8.93-29.34%Miss-35.1%
    Mar 22
    Reported May 4
    		$-10.05$-9.93-1.21%Miss-19.6%
    Dec 21
    Reported Feb 16
    		$-11.55$-10.01-15.38%Miss-1440.0%
    Sep 21
    Reported Nov 3
    		$-8.85$-10.29+13.99%Beat+72.9%
    Jun 21
    Reported Aug 5
    		$-8.55$-10.08+15.18%Beat-1610.0%
    Mar 21
    Reported May 5
    		$-8.40$-12.05+30.29%Beat-
    Dec 20
    Reported Mar 9
    		$-0.75$-0.66-13.64%Miss-
    Sep 20
    Reported Nov 11
    		$-32.71$-27.37-19.51%Miss-
    Jun 20
    Reported Sep 16
    		$-0.50N/A+80.62%Beat-

    Key Metrics

    Valuation
    P/E Ratio-1.16EV/EBITDA-0.24x
    Price/FCF-1.83xFCF Yield-54.66%
    Profitability
    Profit Margin-63.10%Operating Margin-49.50%
    ROE-59.20%ROIC-30.74%
    Financial Health
    Debt/Equity1.01xInterest Coverage-4.34x
    Current Ratio5.19xQuick Ratio4.11x
    Trading Statistics
    Beta1.92Avg Volume143.41K
    52-Week High$16.1652-Week Low$3.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.16
    SMA 20$4.48
    SMA 50$4.50
    SMA 200$4.29
    EMA 10$4.16
    EMA 20$4.31
    EMA 50$4.42
    EMA 200$5.65

    MACD

    Line: -0.16Signal: -0.09Hist: -0.07

    ADX

    ADX: 21.2+DI: 11.9-DI: 26.3

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down100.0
    PSAR$4.77

    Bollinger Bands

    Upper Band$5.31
    Lower Band$3.64
    %B Position3723%(Upper)
    Band Width0.11

    RSI (14-Day)

    Neutral
    35.7

    Momentum Oscillators

    Stoch %K2.5
    Stoch %D6.7
    Williams %R-96.7
    ROC (10d)-15.3%
    Momentum-0.69
    CCI (20d)-131.2
    MFI (14d)21.2

    Volatility Measures

    ATR (14d)$0.31(8.2%)
    StdDev (20d)0.42
    Hist Vol58.6%(High)

    Volume Flow

    VWAP$3.86
    OBV1.8M
    AD Line3.3B
    CMF (20d)-0.045

    Volume Metrics

    Avg Vol (20d)145.9K
    Vol Ratio0.7x
    VWMA (20d)$4.51

    Pivot Points

    R3$4.37
    R2$4.27
    R1$4.11
    Pivot Point$4.01
    S1$3.84
    S2$3.74
    S3$3.58

    Advanced Oscillators

    TSI-13.81
    Ultimate Osc31.8
    KST-80.28

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$31.64M$27.86M$28.87M$29.43M$31.42M$29.75M$29.47M$28.67M$27.39M$28.17M$30.51M$30.36M
    Cost of Revenue$18.35M$15.77M$16.64M$17.84M$19.55M$18.69M$18.72M$18.85M$17.61M$19.95M$22.80M$23.20M
    Gross Profit$13.28M$12.10M$12.23M$11.59M$11.87M$11.07M$10.75M$9.82M$9.78M$8.21M$7.71M$7.16M
    Operating Expenses$28.96M$29.01M$29.86M$27.40M$28.73M$27.46M$32.61M$33.66M$40.55M$45.13M$45.06M$52.61M
    R&D$5.45M$5.62M$5.05M$5.38M$5.29M$5.51M$7.89M$8.14M$9.73M$12.63M$12.53M$16.08M
    SG&A$11.36M$10.12M$11.93M$8.48M$9.16M$8.30M$9.27M$10.10M$12.68M$11.44M$10.34M$11.81M
    Operating Income$-15,676,000$-16,919,000$-17,629,000$-15,813,000$-16,865,000$-16,399,000$-21,860,000$-23,839,000$-30,764,000$-36,912,000$-37,353,000$-45,454,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$3.44M$3.37M$3.44M$3.48M$3.48M$11.24M$5.83M$6.07M$6.01M$5.97M$3.42M$3.21M
    Income Before Tax$-17,764,000$-18,761,000$-19,396,000$-17,434,000$-18,437,000$-25,668,000$-25,642,000$-27,758,000$-34,303,000$-39,782,000$-38,488,000$-46,094,000
    Income Tax Expense$220,000$217,000$95,000$404,000$104,000$115,000$-4,000$182,000$151,000$162,000$112,000$86,000
    Net Income$-17,984,000$-18,978,000$-19,491,000$-17,838,000$-18,541,000$-25,783,000$-25,638,000$-27,940,000$-34,454,000$-39,944,000$-38,600,000$-46,180,000
    EBITDA$-14,080,000$-15,010,000$-15,610,000$-13,636,000$-14,433,000$-13,531,000$-19,241,000$-21,261,000$-28,173,000$-33,931,000$-34,895,000$-43,161,000
    EBIT$-14,322,000$-15,392,000$-15,955,000$-13,958,000$-14,962,000$-14,423,000$-19,817,000$-21,690,000$-28,293,000$-33,814,000$-35,071,000$-42,881,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OM

    News

    Outset Medical Announces Departure of General Counsel Brottem

    Outset Medical (OM) announced that its General Counsel, John Brottem, will depart the company on September 11, 2026, to pursue other professional opportunities. The company clarified that his exit is not due to any disputes, signaling an orderly transition of legal leadership. While the change prompts a search for new legal leadership, it is presented as routine executive turnover to reassure the market.

    TipRanks•8/28/26•
    Neutral

    Outset Medical CFO Renee Gaeta sells $19,943 in stock

    Renee Gaeta, CFO of Outset Medical (NASDAQ: OM), sold 4,543 shares of company stock worth $19,943 on August 17, 2026. This transaction was a "sell to cover" to satisfy tax obligations related to vested Restricted Stock Units, not a discretionary trade. The sale occurred as Outset Medical's stock has seen a significant decline, though InvestingPro analysis suggests it may be undervalued.

    Investing.com•8/19/26•
    Neutral

    Outset Medical CEO Leslie Trigg sells $15,088 in shares By Investing.com

    Outset Medical CEO Leslie Trigg sold 3,437 shares of the company's common stock for $15,088. This transaction was identified as a "sell to cover" to satisfy tax withholding obligations related to the vesting of restricted stock units. Following the sale, Trigg directly and indirectly holds over 236,000 shares of Outset Medical.

    Investing.com Australia•8/19/26•
    Neutral

    Outset Medical general counsel sells $11,554 in stock

    John L. Brottem, General Counsel at Outset Medical, Inc. (NASDAQ:OM), sold 2,632 shares of common stock for $11,554 on August 17, 2026. This "sell to cover" transaction was to fulfill tax withholding obligations related to vested Restricted Stock Units, not a discretionary trade. The stock has since seen a 7% decline, though InvestingPro indicates it may be undervalued, offering further analytical insights for investors.

    Investing.com•8/19/26•
    Somewhat-Bearish

    Leslie Trigg Sells 3,437 Shares of Outset Medical (NASDAQ:OM) Stock

    Outset Medical CEO Leslie Trigg sold 3,437 shares of company stock for $15,088.43 to cover tax obligations, reducing her direct holdings by 1.74%. The company's shares fell 7.3% to $4.18, and it reported a quarterly loss of $0.80 per share, though revenue exceeded estimates. Analysts currently have a "Hold" rating on OM with a consensus price target of $10.00, expecting a full-year loss of $3.80 per share.

    MarketBeat•8/19/26•
    Somewhat-Bearish

    Frequently Asked Questions About OM

    Does OM pay dividends?
    Outset Medical Inc (OM) does not currently pay a regular dividend.
    What is OM's market cap?
    Outset Medical Inc (OM) has a market capitalization of $71.81M with a current stock price of $3.82.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In